Compare QSR & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | QSR | STE |
|---|---|---|
| Founded | 1954 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Specialties |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.9B | 25.9B |
| IPO Year | 2006 | 1992 |
| Metric | QSR | STE |
|---|---|---|
| Price | $69.86 | $255.84 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 9 |
| Target Price | $73.94 | ★ $268.25 |
| AVG Volume (30 Days) | ★ 2.7M | 666.1K |
| Earning Date | 10-30-2025 | 02-04-2026 |
| Dividend Yield | ★ 3.54% | 0.99% |
| EPS Growth | N/A | ★ 59.39 |
| EPS | 2.81 | ★ 6.97 |
| Revenue | ★ $9,264,000,000.00 | $5,702,415,000.00 |
| Revenue This Year | $12.55 | $9.61 |
| Revenue Next Year | $3.91 | $6.23 |
| P/E Ratio | ★ $24.83 | $36.43 |
| Revenue Growth | ★ 16.82 | 7.08 |
| 52 Week Low | $58.71 | $200.98 |
| 52 Week High | $73.70 | $268.60 |
| Indicator | QSR | STE |
|---|---|---|
| Relative Strength Index (RSI) | 47.85 | 49.97 |
| Support Level | $69.75 | $250.46 |
| Resistance Level | $71.37 | $255.31 |
| Average True Range (ATR) | 1.15 | 4.84 |
| MACD | -0.34 | -1.24 |
| Stochastic Oscillator | 2.78 | 41.00 |
Restaurant Brands generates about $44 billion in system sales across more than 32,000 restaurants in over 120 markets, making it one of the largest restaurant companies globally. Its banners include Burger King (7,082 stores), Tim Hortons (4,539), Popeyes (3,520), and Firehouse Subs (1,345), concentrated in the US and Canada, with these brands also comprising 15,639 franchised international locations as of year-end 2024. The firm primarily earns revenue from franchise and property fees, supply chain sales within the Tim Hortons segment, company-operated restaurants, and advertising royalties.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.